New obesity medications, known as glucagon-like peptide-1 (GLP-1) agonists, not only help people lose weight and keep it off
Nausea, vomiting, diarrhoea, bloating, and heartburn are common in the first couple of months
Tirzepatide has a half-life of approximately five days, meaning therapeutic levels decline gradually over several days to weeks after a missed injection rather than disappearing immediately
People who took GLP-1 daily for 24 weeks experienced both weight loss and an increased metabolism
2 NSAIDs like ibuprofen carry a risk of stomach irritation that can overlap with Wegovys gastrointestinal side effects, so its recommended to take them with a meal
The exact prevalence of muscle cramps with Mounjaro is challenging to establish precisely because: 1